TRAW
Traws Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.49
−8.50%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.21
- Revenue estimate
- $2.7M
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.16
- EPS estimate
- -$0.34
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +72.4%
- Revenue beats (12Q)
- 4
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.34 | -$0.16 | Beat 52.24% | — |
| Apr 15, 2026 | -$0.92 | -$0.53 | Beat 42.39% | — |
| Nov 13, 2025 | -$9.16 | -$0.34 | Beat 96.29% | $2.7M |
| Aug 14, 2025 | -$8.75 | -$0.11 | Beat 98.74% | $2.7M |
| May 15, 2025 | -$8.04 | $2.09 | Beat 126.00% | $57.0K |
| Mar 31, 2025 | -$9.55 | $96 | Beat 1101.68% | $56.0K |
| Nov 14, 2024 | -$6.25 | -$8.81 | Miss -40.96% | $56.0K |
| Aug 15, 2024 | -$6.25 | -$122 | Miss -1848.00% | $57.0K |
| May 15, 2024 | -$6.00 | -$6.00 | In line | $113.0K |
| Nov 14, 2023 | -$0.26 | -$0.23 | Beat 11.54% | $113.0K |
| Aug 10, 2023 | -$7.81 | -$5.00 | Beat 36.00% | $57.0K |
| Mar 16, 2023 | -$6.94 | -$6.50 | Beat 6.31% | $46.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026